These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32572458)

  • 1. Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients.
    Wang W; Tichnell C; Murray BA; Agafonova J; Cadrin-Tourigny J; Chelko S; Tandri H; Calkins H; James CA
    Europace; 2020 Aug; 22(8):1270-1278. PubMed ID: 32572458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers.
    Sawant AC; Te Riele AS; Tichnell C; Murray B; Bhonsale A; Tandri H; Judge DP; Calkins H; James CA
    Heart Rhythm; 2016 Jan; 13(1):199-207. PubMed ID: 26321091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
    Bhonsale A; Te Riele ASJM; Sawant AC; Groeneweg JA; James CA; Murray B; Tichnell C; Mast TP; van der Pols MJ; Cramer MJM; Dooijes D; van der Heijden JF; Tandri H; van Tintelen JP; Judge DP; Hauer RNW; Calkins H
    Heart Rhythm; 2017 Jun; 14(6):883-891. PubMed ID: 28215569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy.
    Perrin MJ; Angaran P; Laksman Z; Zhang H; Porepa LF; Rutberg J; James C; Krahn AD; Judge DP; Calkins H; Gollob MH
    J Am Coll Cardiol; 2013 Nov; 62(19):1772-9. PubMed ID: 23810883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.
    Costa S; Medeiros-Domingo A; Gasperetti A; Akdis D; Berger W; James CA; Ruschitzka F; Brunckhorst CB; Duru F; Saguner AM
    Circ Genom Precis Med; 2021 Feb; 14(1):e003047. PubMed ID: 33232181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report.
    Adachi Y; Hayashi T; Mitsuhashi T; Sakakura K; Yamada Y; Wada Y; Horie M; Momomura SI; Fujita H
    BMC Cardiovasc Disord; 2019 Feb; 19(1):41. PubMed ID: 30782136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype?
    Groeneweg JA; van der Zwaag PA; Jongbloed JD; Cox MG; Vreeker A; de Boer RA; van der Heijden JF; van Veen TA; McKenna WJ; van Tintelen JP; Dooijes D; Hauer RN
    Heart Rhythm; 2013 Apr; 10(4):548-59. PubMed ID: 23270881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
    James CA; Bhonsale A; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H
    J Am Coll Cardiol; 2013 Oct; 62(14):1290-1297. PubMed ID: 23871885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.
    Syrris P; Ward D; Asimaki A; Sen-Chowdhry S; Ebrahim HY; Evans A; Hitomi N; Norman M; Pantazis A; Shaw AL; Elliott PM; McKenna WJ
    Circulation; 2006 Jan; 113(3):356-64. PubMed ID: 16415378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations.
    Sawant AC; Bhonsale A; te Riele AS; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H; James CA
    J Am Heart Assoc; 2014 Dec; 3(6):e001471. PubMed ID: 25516436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.
    van Lint FHM; Murray B; Tichnell C; Zwart R; Amat N; Lekanne Deprez RH; Dittmann S; Stallmeyer B; Calkins H; van der Smagt JJ; van den Wijngaard A; Dooijes D; van der Zwaag PA; Schulze-Bahr E; Judge DP; Jongbloed JDH; van Tintelen JP; James CA
    Circ Genom Precis Med; 2019 Aug; 12(8):e002467. PubMed ID: 31386562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
    Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin.
    La Gerche A; Robberecht C; Kuiperi C; Nuyens D; Willems R; de Ravel T; Matthijs G; Heidbüchel H
    Heart; 2010 Aug; 96(16):1268-74. PubMed ID: 20525856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
    Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.
    Rigato I; Bauce B; Rampazzo A; Zorzi A; Pilichou K; Mazzotti E; Migliore F; Marra MP; Lorenzon A; De Bortoli M; Calore M; Nava A; Daliento L; Gregori D; Iliceto S; Thiene G; Basso C; Corrado D
    Circ Cardiovasc Genet; 2013 Dec; 6(6):533-42. PubMed ID: 24070718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
    Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
    Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Smith W;
    Heart Lung Circ; 2011 Dec; 20(12):757-60. PubMed ID: 21885338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Bourfiss M; Te Riele AS; Mast TP; Cramer MJ; VAN DER Heijden JF; VAN Veen TA; Loh P; Dooijes D; Hauer RN; Velthuis BK
    J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1420-1428. PubMed ID: 27572111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Wang W; Orgeron G; Tichnell C; Murray B; Crosson J; Monfredi O; Cadrin-Tourigny J; Tandri H; Calkins H; James CA
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.